Poseida Therapeutics exotic insider transaction detected
| PSTXDelisted Stock | USD 9.50 0.08 0.84% |
Slightly above 62% of Poseida Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Poseida Therapeutics stock suggests that many investors are alarmed at this time. Poseida Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Poseida Therapeutics' earnings reports, geopolitical events, and overall market trends.
Poseida |
Filed transaction by Poseida Therapeutics Inc director. Unconventional Insider trading
Read at macroaxis.com
Poseida Therapeutics Fundamental Analysis
We analyze Poseida Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Poseida Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Poseida Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Poseida Therapeutics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Poseida Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Poseida Therapeutics stock to make a market-neutral strategy. Peer analysis of Poseida Therapeutics could also be used in its relative valuation, which is a method of valuing Poseida Therapeutics by comparing valuation metrics with similar companies.
Peers
Poseida Therapeutics Related Equities
| LTRN | Lantern Pharma | 5.71 | ||||
| RVMD | Revolution Medicines | 5.25 | ||||
| CUE | Cue Biopharma | 4.41 | ||||
| STOK | Stoke Therapeutics | 4.00 | ||||
| RVPH | Reviva Pharmaceuticals | 2.79 | ||||
| CYTK | Cytokinetics | 2.71 | ||||
| DYN | Dyne Therapeutics | 1.49 | ||||
| PHVS | Pharvaris | 0.51 | ||||
| PLRX | Pliant Therapeutics | 0.19 | ||||
| MLYS | Mineralys Therapeutics, | 0.58 | ||||
| ANTX | AN2 Therapeutics | 0.85 | ||||
| MOLN | Molecular Partners | 0.96 | ||||
| IPSC | Century Therapeutics | 3.53 | ||||
| PASG | Passage Bio | 4.92 | ||||
| GBIO | Generation Bio | 5.81 | ||||
| INAB | In8bio | 7.41 | ||||
| PEPG | PepGen | 21.74 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Poseida Stock
If you are still planning to invest in Poseida Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poseida Therapeutics' history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |